T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Abbott
ABT
$192B
| $975M | 0.21% |
23,305,117
+7,099,793
| +44% | +$281M |
|
|
JNPR
127
DELISTED
Juniper Networks
JNPR
| $949M | 0.2% |
37,205,214
+6,624,045
| +22% | +$166M |
|
128
Merck
MRK
$330B
| $940M | 0.2% |
18,612,881
-2,122,114
| -10% | -$104M |
|
|
WCN
129
Waste Connections
WCN
$42.1B
| $936M | 0.2% |
21,740,688
+1,197,873
| +6% | +$48.3M |
|
130
Occidental Petroleum
OXY
$58.3B
| $906M | 0.19% |
13,237,992
-2,748,243
| -17% | -$184M |
|
131
Zoetis
ZTS
$29.9B
| $903M | 0.19% |
20,368,090
+4,599,247
| +29% | +$195M |
|
132
Procter & Gamble
PG
$335B
| $895M | 0.19% |
10,879,310
-1,527,696
| -12% | -$123M |
|
133
Blackrock
BLK
$179B
| $888M | 0.19% |
2,608,081
+560,623
| +27% | +$178M |
|
134
Northern Trust
NTRS
$34.8B
| $886M | 0.19% |
13,593,339
-804,346
| -6% | -$50.4M |
|
135
Loews
L
$23.2B
| $875M | 0.19% |
22,881,703
+1,013,340
| +5% | +$37.3M |
|
136
Qualcomm
QCOM
$170B
| $869M | 0.19% |
17,001,154
-3,596,732
| -17% | -$175M |
|
137
Carnival Corporation Ltd
CCL
$38.1B
| $853M | 0.18% |
16,160,479
-4,498,972
| -22% | -$218M |
|
|
LNKD
138
DELISTED
LinkedIn Corporation
LNKD
| $841M | 0.18% |
7,352,777
-2,058,189
| -22% | -$302M |
|
|
N
139
DELISTED
Netsuite Inc
N
| $836M | 0.18% |
12,202,445
+1,836,940
| +18% | +$120M |
|
140
Trip.com Group
TCOM
$28.8B
| $829M | 0.18% |
18,724,287
+1,600,685
| +9% | +$67M |
|
141
Martin Marietta Materials
MLM
$32.6B
| $820M | 0.18% |
5,139,268
-528,835
| -9% | -$72.7M |
|
142
Flowserve
FLS
$10.2B
| $817M | 0.17% |
18,396,916
-13,916
| -0.1% | -$574K |
|
143
Microchip Technology
MCHP
$43.6B
| $817M | 0.17% |
33,891,596
+2,056,568
| +6% | +$45.8M |
|
144
Edison International
EIX
$26.5B
| $809M | 0.17% |
11,259,338
-2,182,767
| -16% | -$142M |
|
145
EQT Corp
EQT
$33.8B
| $809M | 0.17% |
22,085,092
+4,815,716
| +28% | +$154M |
|
146
IDEX
IEX
$17.6B
| $805M | 0.17% |
9,707,579
-1,347,862
| -12% | -$101M |
|
|
KSU
147
DELISTED
Kansas City Southern
KSU
| $803M | 0.17% |
9,400,990
+3,721,514
| +66% | +$290M |
|
148
Dentsply Sirona
XRAY
$2.25B
| $795M | 0.17% |
12,895,553
+2,688,238
| +26% | +$158M |
|
149
Bruker
BRKR
$8.79B
| $792M | 0.17% |
28,297,945
+225,357
| +0.8% | +$5.62M |
|
150
Fidelity National Financial
FNF
$12.8B
| $792M | 0.17% |
33,643,267
-1,111,211
| -3% | -$24.9M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.